RALLYBIO CORP Share Price Today: Live Updates & Key Insights

RALLYBIO CORP share price today is $8.84, up -2.42%. The stock opened at $9.19 against the previous close of $9.09, with an intraday high of $9.44 and low of $8.965.

RALLYBIO CORP Share Price Chart

RALLYBIO CORP

us-stock
To Invest in {{usstockname}}
us-stock

RALLYBIO CORP Share Price Performance

$8.84 -0.0242(-2.42%) RLYB at 23 Mar 2026 03:02 PM Biotechnology
Lowest Today 8.965
Highest Today 9.44
Today’s Open 9.19
Prev. Close 9.09
52 Week High 11.49
52 Week Low 1.76
Day’s Range: Low 8.965 High 9.44
52-Week Range: Low 1.76 High 11.49
1 day return -
1 Week return -4.47
1 month return +62.9
3 month return +1071.24
6 month return +1367.4
1 year return +1368.85
3 year return +98.66
5 year return -37.77
10 year return -

RALLYBIO CORP Institutional Holdings

Viking Global Investors LP 79.30

Johnson & Johnson 68.74

5AM Venture Management, LLC 68.64

New Leaf Venture Partners, L.L.C. 62.42

TPG GP A, LLC 57.25

Pivotal bioVenture Partners Investment Advisor LLC 45.46

FMR Inc 32.03

Almitas Capital LLC 28.92

Vanguard Group Inc 19.21

Renaissance Technologies Corp 15.80

AJU IB Investment Co Ltd 14.27

Vanguard Total Stock Mkt Idx Inv 12.02

Canaan Partners XI LLC 8.51

Mariner Wealth Advisors LLC 7.65

Vanguard Institutional Extnd Mkt Idx Tr 4.93

Citadel Advisors Llc 4.80

Geode Capital Management, LLC 4.69

Fidelity Global Micro-Cap F 3.31

BlackRock Inc 2.68

Fidelity Extended Market Index 2.29

Susquehanna International Group, LLP 1.90

Vifag 2002 SICAV 1.89

Acadian Asset Management LLC 1.71

State Street Corp 1.17

XTX Topco Ltd 1.12

Blackrock Extended Mkt Fund CF 0.86

Extended Equity Market Fund K 0.74

Fidelity Total Market Index 0.62

Fidelity Series Total Market Index 0.57

PGIM US Micro Cap Quant Equity 0.55

Fidelity Nasdaq Composite Index 0.45

Spartan Extended Market Index Pool F 0.45

NT Ext Equity Mkt Idx Fd - NL 0.40

Spartan Total Market Index Pool G 0.32

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.32

Northern Trust Extended Eq Market Idx 0.30

NT Ext Equity Mkt Idx Fd - L 0.30

Vanguard U.S. Eq Idx £ Acc 0.22

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.12

Extended Equity Market Fund M 0.08

RALLYBIO CORP Market Status

Strong Buy: 1

Buy: 0

Hold: 3

Sell: 0

Strong Sell: 0

RALLYBIO CORP Fundamentals

Market Cap 46.92 M

PB Ratio 0.8096

PE Ratio 0.0

Enterprise Value -7.64 M

Total Assets 62.26 M

Volume 145810

RALLYBIO CORP Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-70525000 -70.5M, FY22:-66487000 -66.5M, FY21:-47010000 -47.0M, FY20:-24925000 -24.9M, FY19:-17626000 -17.6M

Quarterly Revenue Q3/2025:212000 0.2M, Q2/2025:212000 0.2M, Q1/2025:212000 0.2M, Q3/2024:299000 0.3M, Q2/2024:299000 0.3M

Quarterly Profit Q3/2025:212000 0.2M, Q2/2025:212000 0.2M, Q1/2025:212000 0.2M, Q3/2024:299000 0.3M, Q2/2024:265000 0.3M

Quarterly Net worth Q3/2025:16015999 16.0M, Q2/2025:-9703000 -9.7M, Q1/2025:-9439000 -9.4M, Q3/2024:-11466000 -11.5M, Q2/2024:-16236000 -16.2M

About RALLYBIO CORP & investment objective

Company Information Rallybio Corporation, a clinical-stage biotechnology company, engages in the development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases. Its lead product candidate is the RLYB116, an inhibitor of complement component 5 (C5) to treat several diseases of complement dysregulation which has completed phase 1 trial; and RLYB332, a preclinical antibody, for the treatment of severe anemia with ineffective erythropoiesis and iron overload. The company has a strategic alliance with AbCellera to discover, develop, and commercialize novel antibody-based therapeutics for rare diseases, as well as collaboration agreement with Johnson & Johnson to provide therapeutic solutions for pregnant individuals at risk of fetal and neonatal alloimmune thrombocytopenia. Rallybio Corporation was founded in 2018 and is headquartered in New Haven, Connecticut.

Organisation Biotechnology

Employees 15

Industry Biotechnology

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

RALLYBIO CORP FAQs

What is the share price of RALLYBIO CORP today?

The current share price of RALLYBIO CORP is $8.84.

Can I buy RALLYBIO CORP shares in India?

Yes, Indian investors can buy RALLYBIO CORP shares by opening an international trading and demat account with Motilal Oswal.

How to buy RALLYBIO CORP shares in India?

You can easily invest in RALLYBIO CORP shares from India by:

Can I buy fractional shares of RALLYBIO CORP?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of RALLYBIO CORP?

RALLYBIO CORP has a market cap of $46.92 M.

In which sector does RALLYBIO CORP belong?

RALLYBIO CORP operates in the Biotechnology sector.

What documents are required to invest in RALLYBIO CORP stocks?

To invest, you typically need:

What is the PE and PB ratio of RALLYBIO CORP?

The PE ratio of RALLYBIO CORP is N/A and the PB ratio is 0.81.